This information is intended for Connecticut Prescribers
HB 6669
Diabetes Products
Last Update: January 21, 2025
Vaccines
Last Update: January 21, 2025
ALDURAZYME® (laronidase)
Last Update: January 3, 2025
ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]
Last Update: January 3, 2025
ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]
Last Update: January 3, 2025
CABLIVI® (caplacizumab-yhdp)
Last Update: January 3, 2025
CERDELGA® (eliglustat) capsules, for oral use
Last Update: January 3, 2025
Cerezyme® (imiglucerase) for injection
Last Update: January 3, 2025
DUPIXENT® (dupilumab) Injection
Last Update: January 3, 2025
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]
Last Update: January 3, 2025
FABRAZYME® (agalsidase beta) for injection, for intravenous use
Last Update: January 3, 2025
KEVZARA® (sarilumab)
Last Update: January 3, 2025
LEMTRADA® (alemtuzumab)
Last Update: January 3, 2025
LUMIZYME® (alglucosidase alfa)
Last Update: January 3, 2025
MULTAQ® (dronedarone)
Last Update: January 22, 2025
NEXVIAZYME® (avalglucosidase alfa-ngpt) for injection, for intravenous use
Last Update: January 3, 2025
REZUROCK® (belumosudil) tablets
Last Update: January 3, 2025
SARCLISA® (isatuximab-irfc) injection
Last Update: January 3, 2025
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]
Last Update: January 3, 2025
THYROGEN® (thyrotropin alfa for injection)
Last Update: January 15, 2025
TZIELD® (teplizumab-mzwv)
Last Update: January 3, 2025
XENPOZYME® (olipudase alfa-rpcp) for injection, for intravenous use
Last Update: January 3, 2025
House Bill 6669. Published by the General Assembly of the State of Connecticut
Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Cerezyme, Fabrazyme, Kevzara, Lemtrada, Lumizyme, Multaq, Nexviazyme, Thymoglobulin , Xenpozyme
MAT-US-2308341-v4.0-02/2025